Cancer treatments: Latest News, Top Stories & Analysis - Page 5 of 5

SPRING HOUSE, PA — Third Arc Bio Inc. has administered the first dose of ARC101 to a patient in its inaugural first-in-human clinical trial. This milestone marks the company’s transition to …

Cancer / Regional

Wistar Institute Uncovers New Strategy for Treating Resistant Melanoma

February 7, 2025February 6, 2025 - by Timothy Alexander

PHILADELPHIA, PA— Researchers at The Wistar Institute, led by Jessie Villanueva, Ph.D., have made significant strides in combating treatment-resistant melanoma. Their latest discovery focuses on inhibiting the gene S6K2, a breakthrough …